Basecamp Research is dedicated to solving major challenges in the life sciences by exploring Beyond Known Biology. Our teams build frontier AI models using BaseData, the world's largest ethically-sourced and globally representative biological dataset. Our Global Research Team collects and curates our own biological data through partnerships with more than 152 organizations in 28 countries, giving its AI access to genetic diversity that doesn't exist for models trained on public database sources. This enables Basecamp Research to design novel protein sequences and biological systems that can accelerate therapeutic research and development.
In October 2024 we closed Series B and in January 2026 finalised pre-Series C investment from NVIDIA. With hubs both in London, UK as well as Boston Massachusetts, USA and partners with biopharma companies and academic institutions worldwide, our work has been recognized with honors including Fast Company's Top 10 Most Innovative Companies in Biotech and the FT-backed Sifted AI100 list of Europe's leading AI startups.
At Basecamp Research, we pride ourselves on being a diverse, exciting, fun, and flexible place to work. Our team of biologists, engineers, ML scientists, field explorers, and operations specialists are united by a sense of adventure and the belief that nature has already designed the solutions to our planet’s greatest challenges - we just need to go out and discover them! If you feel passionate about the power of biology, data, and AI to build a better world, we’d love to hear from you.
The global pharmaceutical industry is undergoing a once-in-a-generation shift. AI is becoming central to how drugs are discovered, and the companies that control the richest, most biologically diverse training data will define what is possible. Basecamp Research sits at exactly that frontier, and we are looking for a Senior Director, Business Development Pharma AI to build and lead our most strategically important commercial relationships with global pharma.
This is a senior, high-impact role reporting directly to the Chief Business Officer. You will own the full lifecycle of Basecamp Research’s enterprise relationships with major pharmaceutical companies - from initial engagement with Chief Scientist, VP-Level R&D, and BD leaders through to the design, negotiation, and execution of multi-year strategic collaborations covering AI, data access, and biological platform partnerships. Over time, you will shape how global pharma thinks about accessing and partnering on next-generation biological AI.
You understand how large pharma organisations think about AI strategy, external innovation, and data infrastructure. You have a credible track record of building enterprise-level relationships in TechBio, AI, or life sciences platforms, and you know how to translate complex scientific and computational capabilities into compelling, commercially viable propositions for a demanding, sophisticated audience.
Enterprise Partnership Strategy
Own Basecamp Research’s global pharma partnership strategy - mapping the landscape of major pharmaceutical companies, identifying where Basecamp’s biological AI and BaseData platform and therapeutic drug discovery capabilities can most powerfully intersect with their R&D and AI strategies.
Develop and execute a playbook for entering, deepening, and scaling enterprise relationships with global pharma, covering target identification, value proposition design and long-term partnership management.
Stay closely attuned to how major pharma companies are evolving their approach to AI in drug discovery - including build vs. buy vs. partner decisions, training data procurement strategy, and computational platform partnership - and position Basecamp Research ahead of that demand.
Identify and develop novel commercial models suited to enterprise pharma: multi-year platform access agreements, co-development of biological foundation models, exclusive data collaboration windows, and milestone-linked R&D partnerships.
Relationship Development & Deal Execution
Build and manage a portfolio of C-Suite, Chief Scientist, and VP R&D relationships at priority pharmaceutical accounts, acting as Basecamp Research’s senior face in strategic commercial conversations.
Lead the full deal lifecycle for enterprise pharma transactions - from opportunity origination, through commercial structuring and scientific scoping, to term sheet negotiation and contract execution - operating as a commercial extension of the leadership team.
Design creative, balanced deal structures that reflect the strategic value of long-term relationships: multi-year data access tiers, co-development economics, milestone and royalty arrangements, exclusivity provisions, and equity components where applicable.
Maintain a disciplined, high-quality partnership pipeline and bring rigour to forecasting and deal velocity without unnecessary process overhead.
Scientific & Platform Translation
Act as a credible scientific commercial translator - distilling Basecamp Research’s complex biological and AI capabilities into clear, differentiated value propositions for pharma R&D audiences spanning computational biology, drug discovery, genomics, and precision medicine.
Work closely with Basecamp’s science, product, and engineering teams to ensure partnerships commitments are technically grounded and to surface partner requirements that should share our platform roadmap.
Represent the voice of global pharma customers internally, translating what major R&D organisations actually need from biological AI and biodiversity data into product, data,and capability priorities.
Produce high-quality partner-facing materials, scientific narratives, and commercial proposals that credibly represent the frontier of what Basecamp Research is building.
Thought Leadership & Ecosystem Presence
Represent Basecamp Research at major life sciences and AI conferences, pharma partnering events, and industry forums - cultivating a strong personal network and generating inbound interest from major pharma organisations.
Contribute to Basecamp Research’ external positioning and thought leadership at the intersection of biological AI, biodiversity data, and drug discovery.
Help build the commercial foundation for a growing enterprise partnerships function - contributing to hiring, process design, and team culture as deal volume and relationship complexity scales.
8+ years of experience in business development, strategic alliances, enterprise partnerships, or commercial strategy within the pharmaceutical, biotechnology, or AI/ML-driven life sciences sector.
Proven track record of building and closing high-value, complex strategic partnership with global pharmaceutical organisations at the enterprise level - not transactional licensing but multi-year platform or data collaborations.
Deep familiarity with how major pharma companies approach AI and external innovation: how they think about computational platforms, training data procurement, foundation model development, and strategic data partnerships.
Credible scientific or technical fluency in AI/ML applied to drug discovery, computational biology, genomics, or related fields - able to engage meaningfully with researchers and computational scientists, not just commercial counterparts.
Strong executive presence and comfort operating at the C-Suite and VP level with sophisticated, scientifically literate counterparts at global pharma companies.
Experience designing and negotiating non-standard, creative deal structures - comfortable inventing commercial frameworks, not just filling in templates.
Based in the Boston, MA or London, UK with willingness to travel internationally for key partner engagements and conferences.
Prior experience in a TechBio, BioPharma, AI drug discovery, or AI data company in a BD, partnerships or commercial role.
Existing senior network within global pharma R&D, computational biology, or AI strategy functions at major pharmaceutical companies
Familiarity with the economics and commercial architecture of therapeutic licensing and AI-pharma partnerships - including how training data, fine-tuning, and platform access deals are structured and valued.
Background in a high-growth, early-stage environment where you have built partnership motion, commercial infrastructure, or team capability from the ground up.
Exposure to biodiversity, genomics, protein design, or related frontier biology - either through prior work or deep personal interest.
Advanced degree (PhD, MBA, or equivalent) in a relevant scientific or business discipline.
Impactful Mission: This is a rare opportunity to do work that genuinely matters. You'll join a talented, fast-moving team, access unique biological datasets at scale, and see your contributions shape real breakthroughs in AI and curative therapeutics.
Collaborative Culture: You'll be surrounded by world-class engineers, scientists, and researchers who care deeply about their work and about each other. With offices in Boston and London, we've built a flexible, cross-functional environment where personal development and real ownership aren't just talking points.
High Growth: We truly believe in investing in our people and their development, we have twice yearly promotion opportunities. People who are really successful here own it and go directly to solve problems at pace and we ensure reward increases with impact.
Comprehensive Benefits: We've built a benefits package people value. That means competitive salary, equity, pension plan, and healthcare so strong that most employees' family members opt into our plan over their own.
Salary Range: $175,000 - $245,000 base depending on skills and experience.
Do you want to join our team as our new Senior Director, Business Development Pharma AI? Then we'd love to hear about you!
We are committed to equal opportunity employment regardless of ethnic or national origin, race, religion, sex, age, citizenship, sexual orientation, marital status, disability, gender identity or any other basis. If you have a disability or additional need that needs accommodating do let us know.
